Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users—New York, November 2004–April 2007

[Guest guest]

http://jama.ama-assn.org/cgi/content/full/300/1/34

JAMA

Vol. 300 No. 1, July 2, 2008

From the Centers for Disease Control and Prevention: Morbidity and Mortality

Weekly Report

Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster

Among Young Injection-Drug Users—New York, November 2004–April 2007

JAMA. 2008;300(1):34-36.

MMWR. 2008;57:517-521

1 table omitted

Infection with hepatitis C virus (HCV) is a leading cause of chronic liver

disease in the United States.1 Chronic hepatitis B and C virus infections were

added to the nationally notifiable diseases list in 2003.2 Approximately 3.2

million persons in the United States have chronic HCV infection.3 The most

common risk factor for HCV infection is illicit drug use (specifically

injection-drug use [iDU]),3-4 although approximately one third to one half of

cases have no identified risk factor4 (New York State Department of Health

[NYSDOH], unpublished data, 2008). Because approximately 80% of acute HCV

infections are asymptomatic and no serologic markers for recent infection exist,

distinguishing recent from distant infection based on serology alone is

challenging5 and establishment of national HCV infection incidence is difficult.

CDC provides funding to enhance surveillance for HCV infection and other forms

of viral hepatitis in New York State (NYS) and seven other areas. One project of

enhanced surveillance is to identify those HCV infections most likely to have

been acquired recently. Since January 2006, NYSDOH has prioritized follow-up of

positive laboratory markers for HCV infection among persons aged

_________________________________________________________________

The i’m Talkaton. Can 30-days of conversation change the world?

http://www.imtalkathon.com/?source=EML_WLH_Talkathon_ChangeWorld

[Guest guest]

http://jama.ama-assn.org/cgi/content/full/300/1/34

JAMA

Vol. 300 No. 1, July 2, 2008

From the Centers for Disease Control and Prevention: Morbidity and Mortality

Weekly Report

Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster

Among Young Injection-Drug Users—New York, November 2004–April 2007

JAMA. 2008;300(1):34-36.

MMWR. 2008;57:517-521

1 table omitted

Infection with hepatitis C virus (HCV) is a leading cause of chronic liver

disease in the United States.1 Chronic hepatitis B and C virus infections were

added to the nationally notifiable diseases list in 2003.2 Approximately 3.2

million persons in the United States have chronic HCV infection.3 The most

common risk factor for HCV infection is illicit drug use (specifically

injection-drug use [iDU]),3-4 although approximately one third to one half of

cases have no identified risk factor4 (New York State Department of Health

[NYSDOH], unpublished data, 2008). Because approximately 80% of acute HCV

infections are asymptomatic and no serologic markers for recent infection exist,

distinguishing recent from distant infection based on serology alone is

challenging5 and establishment of national HCV infection incidence is difficult.

CDC provides funding to enhance surveillance for HCV infection and other forms

of viral hepatitis in New York State (NYS) and seven other areas. One project of

enhanced surveillance is to identify those HCV infections most likely to have

been acquired recently. Since January 2006, NYSDOH has prioritized follow-up of

positive laboratory markers for HCV infection among persons aged

_________________________________________________________________

The i’m Talkaton. Can 30-days of conversation change the world?

http://www.imtalkathon.com/?source=EML_WLH_Talkathon_ChangeWorld

[Guest guest]

http://jama.ama-assn.org/cgi/content/full/300/1/34

JAMA

Vol. 300 No. 1, July 2, 2008

From the Centers for Disease Control and Prevention: Morbidity and Mortality

Weekly Report

Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster

Among Young Injection-Drug Users—New York, November 2004–April 2007

JAMA. 2008;300(1):34-36.

MMWR. 2008;57:517-521

1 table omitted

Infection with hepatitis C virus (HCV) is a leading cause of chronic liver

disease in the United States.1 Chronic hepatitis B and C virus infections were

added to the nationally notifiable diseases list in 2003.2 Approximately 3.2

million persons in the United States have chronic HCV infection.3 The most

common risk factor for HCV infection is illicit drug use (specifically

injection-drug use [iDU]),3-4 although approximately one third to one half of

cases have no identified risk factor4 (New York State Department of Health

[NYSDOH], unpublished data, 2008). Because approximately 80% of acute HCV

infections are asymptomatic and no serologic markers for recent infection exist,

distinguishing recent from distant infection based on serology alone is

challenging5 and establishment of national HCV infection incidence is difficult.

CDC provides funding to enhance surveillance for HCV infection and other forms

of viral hepatitis in New York State (NYS) and seven other areas. One project of

enhanced surveillance is to identify those HCV infections most likely to have

been acquired recently. Since January 2006, NYSDOH has prioritized follow-up of

positive laboratory markers for HCV infection among persons aged

_________________________________________________________________

The i’m Talkaton. Can 30-days of conversation change the world?

http://www.imtalkathon.com/?source=EML_WLH_Talkathon_ChangeWorld

[Guest guest]

http://jama.ama-assn.org/cgi/content/full/300/1/34

JAMA

Vol. 300 No. 1, July 2, 2008

From the Centers for Disease Control and Prevention: Morbidity and Mortality

Weekly Report

Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster

Among Young Injection-Drug Users—New York, November 2004–April 2007

JAMA. 2008;300(1):34-36.

MMWR. 2008;57:517-521

1 table omitted

Infection with hepatitis C virus (HCV) is a leading cause of chronic liver

disease in the United States.1 Chronic hepatitis B and C virus infections were

added to the nationally notifiable diseases list in 2003.2 Approximately 3.2

million persons in the United States have chronic HCV infection.3 The most

common risk factor for HCV infection is illicit drug use (specifically

injection-drug use [iDU]),3-4 although approximately one third to one half of

cases have no identified risk factor4 (New York State Department of Health

[NYSDOH], unpublished data, 2008). Because approximately 80% of acute HCV

infections are asymptomatic and no serologic markers for recent infection exist,

distinguishing recent from distant infection based on serology alone is

challenging5 and establishment of national HCV infection incidence is difficult.

CDC provides funding to enhance surveillance for HCV infection and other forms

of viral hepatitis in New York State (NYS) and seven other areas. One project of

enhanced surveillance is to identify those HCV infections most likely to have

been acquired recently. Since January 2006, NYSDOH has prioritized follow-up of

positive laboratory markers for HCV infection among persons aged

_________________________________________________________________

The i’m Talkaton. Can 30-days of conversation change the world?

http://www.imtalkathon.com/?source=EML_WLH_Talkathon_ChangeWorld